Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Lineage Cell Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +9 vs. Q3 2021
- Shares held
- 74.4M
- −1.45M (−1.9%) vs. Q3 2021
- Total value
- $182.0M
- −$9.76M (−5.1%) vs. Q3 2021
- New holders
- 25
- 27 more added
- Sold out
- 16
- 39 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 266,076 | $652.0K | 0.00% | +203,527+325.4% | Added |
| STRS Ohio | 282,700 | $692.0K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 406,930 | $745.0K | 0.00% | −34,661−7.8% | Reduced |
| Ameriprise Financial Inc | 304,989 | $747.0K | 0.00% | +304,989 | New |
| Charles Schwab Investment Management Inc | 315,354 | $773.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 333,220 | $816.0K | 0.00% | +313,795+1,615.4% | Added |
| DekaBank Deutsche Girozentrale | 365,500 | $887.0K | 0.00% | −184,500−33.5% | Reduced |
| Bank of New York Mellon Corp | 421,244 | $1.03M | 0.00% | −3,765−0.9% | Reduced |
| Allspring Global Investments Holdings, LLC | 522,913 | $1.28M | 0.00% | +522,913 | New |
| Wells Fargo & Company | 524,841 | $1.29M | 0.00% | −179,603−25.5% | Reduced |
| Morgan Stanley | 528,557 | $1.29M | 0.00% | +403,214+321.7% | Added |
| Two Sigma Investments, LP | 540,824 | $1.32M | 0.00% | −39,964−6.9% | Reduced |
| Raffles Associates LP | 543,590 | $1.33M | 1.28% | +450,000+480.8% | Added |
| Northern Trust Corp | 1,080,924 | $2.65M | 0.00% | −416,703−27.8% | Reduced |
| Two Sigma Advisers, LP | 1,090,366 | $2.67M | 0.01% | −22,000−2.0% | Reduced |
| JPMorgan Chase & Co | 1,283,277 | $3.15M | 0.00% | −932,515−42.1% | Reduced |
| Prescott General Partners LLC | 1,851,851 | $4.54M | 0.16% | 00.0% | Unchanged |
| State Street Corp | 2,074,234 | $5.08M | 0.00% | −3,384,217−62.0% | Reduced |
| Geode Capital Management, LLC | 2,330,151 | $5.71M | 0.00% | −11,363−0.5% | Reduced |
| Defender Capital, LLC. | 4,997,870 | $12.2M | 3.93% | +199,600+4.2% | Added |
| Vanguard Group Inc | 5,961,655 | $14.6M | 0.00% | +5,021+0.1% | Added |
| BlackRock Inc. | 10,008,510 | $24.5M | 0.00% | +1,456,810+17.0% | Added |
| Broadwood Capital Inc | 34,005,379 | $83.3M | 5.12% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 2 | – | – | +2 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −359,381−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −193,756−100.0% | Sold out |
| Laidlaw Wealth Management LLC | 0 | $0 | 0.00% | −104,841−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −96,762−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −62,869−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −42,533−100.0% | Sold out |
| Sightline Wealth Advisors, LLC | 0 | $0 | 0.00% | −14,958−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −13,807−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −11,077−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −11,095−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Godsey & Gibb Associates | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −396−100.0% | Sold out |
| Community Bank, N.A. | 0 | $0 | 0.00% | −508−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |